Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Tags:
Big Pharma, cancer, oncology, Merck, Keytruda, AbbVie, Vraylar, Gilead Sciences, Trodelvy, Sanofi, Sarclisa, Novartis, ligelizumab
Why AbbVie Just Made a $1.8 Billion Gene Therapy Deal
Motley Fool
Sat, 09/25/21 - 11:00 pm
Tags:
AbbVie, Regenxbio, gene therapy, wet age-related macular degeneration
CEOs of AbbVie, BMS, Lilly, GSK and more raise concerns about Washington's intensifying drug-pricing push
Fierce Pharma
Thu, 09/16/21 - 10:50 am
Tags:
drug pricing, Medicare, Pharma CEOs, Eli Lilly, AbbVie, Bristol Myers Squibb, Biogen, GSK
ObsEva files uterine fibroid drug in US, chasing AbbVie, Myovant
Pharmaforum
Wed, 09/15/21 - 10:46 am
Tags:
ObsEva, uterine fibroids, AbbVie, Myovant, FDA, linzagolix
AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit
Fierce Pharma
Tue, 09/14/21 - 10:34 pm
Tags:
AbbVie, Shire, hedge funds, M&A
AbbVie, Regenxbio enter deal to develop retinal disease therapy
Reuters
Mon, 09/13/21 - 10:29 am
Tags:
AbbVie, Regenxbio, RGX-314, gene therapy, retinal disease
No dice: Court tells AbbVie it can't force Takeda to supply a drug that's in shortage worldwide
Fierce Pharma
Thu, 09/9/21 - 11:09 am
Tags:
AbbVie, Takeda, Lupron, drug shortages, legal
AbbVie's stock and next megablockbuster take hits following new JAK warnings from FDA
Endpoints
Wed, 09/1/21 - 11:16 pm
Tags:
AbbVie, Pfizer, Rinvoq, JAK inhibitors, FDA
AbbVie’s Rinvoq is first JAK drug cleared in EU for atopic dermatitis
Pharmaforum
Wed, 08/25/21 - 09:19 pm
Tags:
AbbVie, Rinvoq, Europe, atopic dermatitis, FDA
Court upholds AbbVie's patents on blockbuster cancer drug Imbruvica, generics unlikely until 2032
Endpoints
Fri, 08/20/21 - 12:33 pm
Tags:
AbbVie, Imbruvica, patents, legal, generics
Visus, with one drug chasing AbbVie, inks deals to grow pipeline
Fierce Biotech
Thu, 08/19/21 - 10:45 am
Tags:
Visus Therapeutics, AbbVie, R&D, glaucoma, eye health
As AbbVie and Soliton shake hands on a $550M merger, the FTC says 'not so fast'
Endpoints
Wed, 08/11/21 - 12:14 pm
Tags:
AbbVie, Soliton, Resonic, M&A, FTC
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Fierce Biotech
Tue, 08/10/21 - 10:28 am
Tags:
Visus Therapeutics, AbbVie, Eyenovia, funding, presbyopia
AbbVie hands back headline drug in $63B Allergan buyout to Molecular Partners after FDA rejection. What's next?
Endpoints
Mon, 08/9/21 - 11:54 pm
Tags:
AbbVie, Allergan, Molecular Partners
AbbVie, on a Mission, picks Alzheimer's, Parkinson's targets, as partner nabs $20M
Fierce Biotech
Mon, 08/9/21 - 11:05 am
Tags:
AbbVie, Mission Therapeutics, Parkinson's Disease, Alzheimer's disease
Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Mon, 08/2/21 - 09:40 pm
Tags:
Takeda, AbbVie, Shire, taxes, M&A
FTC drops AbbVie antitrust case, but fires a parting shot at the firm
Pharmaforum
Mon, 08/2/21 - 10:52 am
Tags:
AbbVie, FTC, Androgel, competition
AbbVie's post-Humira stalwarts Skyrizi, Rinvoq performing exactly as hoped, CEO says
Fierce Pharma
Sat, 07/31/21 - 10:07 pm
Tags:
AbbVie, earnings, Humira, Skyrizi, Rinvoq
How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market
Motley Fool
Thu, 07/29/21 - 11:12 am
Tags:
AbbVie, Roche, Venclexta, MDS, breakthrough therapy
AbbVie hits go on $1B re-upped Calico deal as the Google life science spin-out continues I-O, neuro push
Fierce Biotech
Tue, 07/27/21 - 04:34 pm
Tags:
AbbVie, Calico, Google, Alphabet

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.